Literature DB >> 1761825

Sources of countervailing power in medicine.

D Mechanic1.   

Abstract

In recent years a substantial literature has emerged on the alleged deprofessionalization and proletarianization of physicians. The contention is that corporatization is transforming the practice of medicine, divesting physicians of control over many features of their work, consistent with the needs of advanced capitalism. I examine the hypothesis skeptically, differentiating between the cultural role of medicine, the political and social legitimacy of medical concepts, and the personal autonomy of the individual physician. I suggest that while physicians are less autonomous than they used to be, the constraints imposed on them fall within a medical paradigm. From a cultural or social perspective, medicine is more central to the economy and more powerful than ever before. As its centrality and importance increase, there is more at stake, and interests compete more aggressively. I conclude that there is little evidence in support of the hypothesis.

Mesh:

Year:  1991        PMID: 1761825     DOI: 10.1215/03616878-16-3-485

Source DB:  PubMed          Journal:  J Health Polit Policy Law        ISSN: 0361-6878            Impact factor:   2.265


  4 in total

1.  A loss of faith: the sources of reduced political legitimacy for the American medical profession.

Authors:  Mark Schlesinger
Journal:  Milbank Q       Date:  2002       Impact factor: 4.911

2.  Patient-physician relationship in the aftermath of war.

Authors:  V Stambolovic; M Duric; D Donic; J Kelecevic; Z Rakocevic
Journal:  J Med Ethics       Date:  2006-12       Impact factor: 2.903

3.  Policy lessons from physicians' strikes.

Authors:  Gregory P Marchildon
Journal:  Isr J Health Policy Res       Date:  2013-09-17

4.  "A manager in the minds of doctors:" a comparison of new modes of control in European hospitals.

Authors:  Ellen Kuhlmann; Viola Burau; Tiago Correia; Roman Lewandowski; Christos Lionis; Mirko Noordegraaf; Jose Repullo
Journal:  BMC Health Serv Res       Date:  2013-07-02       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.